monday

Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026

March 08, 2026 14:00 ET  | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, March 08, 2026 (GLOBE NEWSWIRE)…

2 weeks ago

KIAASA Retail Limited’s Initial Public Offering to open on Monday, February 23, 2026, price band set at Rs 121 – Rs 127 per Equity Share

Price band of Rs 121– Rs 127 per Equity Share bearing face value of Rs 10 each ("Equity Shares")Bid/Offer Opening Date…

4 weeks ago

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

December 07, 2025 16:00 ET  | Source: Wave Life Sciences USA, Inc. CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) --…

3 months ago

Adyen Processes Record $43 billion as Black Friday/Cyber Monday Weekend Sets New Benchmark for Global Payments

Contactless is the Standard: The share of contactless in-store POS transactions rose from 81% last year to 85% this yearShopper…

4 months ago

Xinhua Silk Road: Annual Conference of Financial Street Forum 2025 kicks off Monday, highlighting high-quality global financial development

BEIJING, Oct. 30, 2025 /PRNewswire/ -- The Annual Conference of Financial Street Forum 2025 kicked off here on Monday, bringing…

5 months ago

Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…

6 months ago

MBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22

September 19, 2025 16:18 ET  | Source: MBX Biosciences, Inc. CARMEL, Ind., Sept. 19, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences,…

6 months ago

PolyPid to Host Conference Call and Webcast to Discuss D-PLEX SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025

June 06, 2025 16:05 ET  | Source: PolyPid Ltd. PETACH TIKVA, Israel, June 06, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD),…

9 months ago